|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.4 AUD | +2.19% |
|
+2.19% | -3.11% |
| Apr. 01 | Cogstate Amends License Agreement with Eisai for Alzheimer’s Treatment | MT |
| Feb. 22 | Cogstate's Fiscal H1 Attributable Profit Jumps, Revenue Rises 3%; Shares Decline 8% | MT |
Cogstate Limited (ASX:CGS) announces a share repurchase program. Under the program, the company will repurchase up to AUD 13 million worth of its ordinary shares. The purpose of the program is to improve returns for shareholders.
The program is valid till March 19, 2024. As of February 28, 2023, the company had 173,459,998 shares issued and outstanding.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.11% | 158M | |
| +25.69% | 47.86B | |
| +46.90% | 41.42B | |
| -3.46% | 40.66B | |
| -6.20% | 28.92B | |
| +9.17% | 25.55B | |
| -20.42% | 19.27B | |
| +28.07% | 12.14B | |
| +0.17% | 12.15B | |
| -1.24% | 11.99B |
COGSTATE LIMITED 
